Guangdong Hybribio Biotech Co Ltd (300639) — Cash Flow Quality Index
Guangdong Hybribio Biotech Co Ltd (300639) has a Cash Flow Quality Index of 2.40x as of September 2023. Operating cash flow of CN¥118.07 Million exceeds net income of CN¥49.26 Million, indicating high earnings quality where cash backs reported profits. Also explore Guangdong Hybribio Biotech Co Ltd balance sheet assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Guangdong Hybribio Biotech Co Ltd Cash Flow Quality Index (2012–2023)
Historical Cash Flow Quality Index for Guangdong Hybribio Biotech Co Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Guangdong Hybribio Biotech Co Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Guangdong Hybribio Biotech Co Ltd (2012–2023)
Year-by-year earnings quality comparison for Guangdong Hybribio Biotech Co Ltd. For live market cap and the full company financial profile, see market value of Guangdong Hybribio Biotech Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 2.28x | CN¥319.60 Million | CN¥140.47 Million | ▲ +213.0% |
| 2022 | 0.73x | CN¥1.31 Billion | CN¥1.80 Billion | ▲ +1.9% |
| 2021 | 0.71x | CN¥631.34 Million | CN¥884.94 Million | ▼ -9.6% |
| 2020 | 0.79x | CN¥311.30 Million | CN¥394.66 Million | ▼ -4.3% |
| 2019 | 0.82x | CN¥112.83 Million | CN¥136.96 Million | ▲ +9.4% |
| 2018 | 0.75x | CN¥80.39 Million | CN¥106.74 Million | ▼ -12.7% |
| 2017 | 0.86x | CN¥79.17 Million | CN¥91.76 Million | ▲ +1.1% |
| 2016 | 0.85x | CN¥63.63 Million | CN¥74.56 Million | ▲ +13.4% |
| 2015 | 0.75x | CN¥48.47 Million | CN¥64.42 Million | ▲ +37.8% |
| 2014 | 0.55x | CN¥34.65 Million | CN¥63.46 Million | ▼ -30.4% |
| 2013 | 0.78x | CN¥22.89 Million | CN¥29.17 Million | ▼ -3.8% |
| 2012 | 0.82x | CN¥16.08 Million | CN¥19.73 Million | — |